Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

SANDOZ

  • FDA Approval
  • Jan. 20, 2025, 09:46 UTC
  • 76
  • 0 comments

FDA approve TRIFLUOPERAZINE HYDROCHLORIDE

Comment Full text

SANDOZ

  • FDA Approval
  • Jan. 20, 2025, 09:46 UTC
  • 77
  • 0 comments

FDA approve TRIFLUOPERAZINE HYDROCHLORIDE

Comment Full text

GRAVITI PHARMS

  • FDA Approval
  • Jan. 20, 2025, 05:24 UTC
  • 76
  • 0 comments

FDA approve PANTOPRAZOLE SODIUM

Comment Full text

DAIICHI SANKYO INC

  • FDA Approval
  • Jan. 17, 2025, 19:34 UTC
  • 89
  • 0 comments

FDA approve DATOPOTAMAB DERUXTECAN-DINK

Comment Full text

TARO PHARM INDS LTD

  • FDA Approval
  • Jan. 17, 2025, 14:47 UTC
  • 74
  • 0 comments

FDA approve TICAGRELOR

Comment Full text

AZURITY

  • FDA Approval
  • Jan. 17, 2025, 13:24 UTC
  • 71
  • 0 comments

FDA approve SITAGLIPTIN

Comment Full text

AMGEN INC

  • FDA Approval
  • Jan. 17, 2025, 09:39 UTC
  • 78
  • 0 comments

FDA approve SOTORASIB

Comment Full text

CAPLIN

  • FDA Approval
  • Jan. 17, 2025, 09:39 UTC
  • 68
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • Jan. 17, 2025, 09:39 UTC
  • 71
  • 0 comments

FDA approve NALOXONE HYDROCHLORIDE

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • Jan. 17, 2025, 09:39 UTC
  • 72
  • 0 comments

FDA approve DESVENLAFAXINE SUCCINATE

Comment Full text
  • Previous
  • 248
  • 249
  • 250
  • 251
  • 252
  • Next

Search

News categories

  • Technical Exchange News(11417)
  • Event(3090)
  • SEC News(209465)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(135918)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin